Model for human skin reconstructed in vitro composed of associated dermis and epidermis

Modelo de pele humana reconstruída in vitro composta de derme e epiderme associadas

ORIGINAL ARTICLE

Model for human skin reconstructed in vitro composed of associated dermis and epidermis

Modelo de pele humana reconstruída in vitro composta de derme e epiderme associadas

Luís Ricardo Martinhão Souto; Jussara Rehder; José Vassallo; Maria Letícia Cintra; Maria Helena Stangler Kraemer; Maria Beatriz Puzzi

Skin Cell Culture Laboratory, Faculdade de Ciências Médicas, Universidade Estadual de Campinas (Unicamp), Campinas, São Paulo, Brazil

^{Address for correspondence}

ABSTRACT

CONTEXT AND OBJECTIVE: The technique of obtaining human skin with dermis and epidermis reconstructed from cells isolated from patients can enable autologous skin grafting on patients with few donor sites. It also enables in vitro trials on chemicals and drugs. The objective of this work was to demonstrate a method for obtaining human skin composed of associated dermis and epidermis, reconstructed in vitro.

DESIGN AND SETTING: Experimental laboratory study, in the Skin Cell Culture Laboratory of Faculdade de Ciências Médicas, Universidade Estadual de Campinas.

METHODS: Cells from human fibroblast cultures are injected into bovine collagen type I matrix and kept immersed in specific culturing medium for fibroblasts. This enables human dermis reconstruction in vitro. On this, by culturing human keratinocytes and melanocytes, differentiated epidermis is formed, leading to the creation of human skin composed of associated dermis and epidermis, reconstructed in vitro.

RESULTS: We showed that human skin composed of associated dermis and epidermis can be successfully reconstructed in vitro. It is histologically formed in the same way as human skin in vivo. Collagen tissue can be identified in the dermis, with cells and extracellular matrix organized in parallel to multilayer epidermis.

CONCLUSIONS: It is possible to obtain completely differentiated human skin composed of associated dermis and epidermis, reconstructed in vitro, from injection of human fibroblasts into bovine collagen type I matrix and culturing of human keratinocytes and melanocytes on this matrix.

Key words: Cell culture. Collagen. Fibroblasts. Keratinocytes. Skin.

RESUMO

CONTEXTO E OBJETIVO: A técnica para obtenção de pele humana que apresente derme e epiderme, reconstruída a partir de células isoladas de pacientes, pode possibilitar a realização de enxertos autólogos de pele reconstruída em laboratório em pacientes com áreas doadoras escassas, além de permitir ensaios com substâncias químicas e drogas in vitro e não mais in vivo. O objetivo do trabalho é demonstrar um método de obtenção de pele humana reconstruída in vitro composta de derme e epiderme associadas.

TIPO DE ESTUDO E LOCAL: Estudo experimental laboratorial realizado no Laboratório de Cultura de Células da Pele da Faculdade de Ciências Médicas da Universidade Estadual de Campinas, Campinas, São Paulo, Brasil.

MÉTODOS: A partir da cultura de fibroblastos humanos, é possível obter um número suficiente de células que podem ser injetadas em uma matriz de colágeno bovino tipo I que, mantida imersa em meio de cultura específico para fibroblastos, permite a formação de uma derme humana reconstruída in vitro. Sobre essa derme, por meio de cultura de queratinócitos e melanócitos humanos, forma-se epiderme diferenciada, levando à formação de pele humana reconstruída in vitro, composta de derme e epiderme associadas.

RESULTADOS: Demonstramos que é possível reproduzir pele humana reconstruída in vitro, composta de derme e epiderme associadas. Essa pele humana formada é, histologicamente, semelhante à pele humana in vivo. Na derme, identifica-se o tecido colágeno, com suas células, e a matriz extracelular organizados paralelamente à epiderme. Esta se desenvolve em várias camadas.

CONCLUSÃO: É possível obter pele humana reconstruída in vitro, completamente diferenciada, composta de derme e epiderme, associadas, a partir da injeção de fibroblastos humanos em uma matriz de colágeno bovino tipo I e da cultura seqüencial de queratinócitos e melanócitose humanos sobre essa matriz contendo fibroblastos em seu interior.

Palavras-chave: Cultura de células. Colágeno. Fibroblastos. Queratinócitos. Pele.

INTRODUCTION

The skin is the largest organ in the human body. In adults, its area ranges from 1.5 to 2.0 m² and its weight from 8 to 10 kg. It contains around 1.0 x 10¹¹ cells of epithelial, mesenchymal and neural origin and is composed of three distinct layers: the subcutaneous tissue (hypodermis), the dermis and the epidermis.¹

The dermis is composed of dense collagen and elastic fibers produced by cutaneous fibroblasts, and the characteristics and distribution of these fibroblasts ensure the physical consistency of the skin (texture and elasticity).² The epidermis contains keratinocytes close to the stratum germinativum (basal layer), and these ensure its renovation. It also contains melanocytes, the cells responsible for skin pigmentation and melanin synthesis. The melanin produced is progressively transferred to the keratinocytes.³

When a lesion occurs, the skin repairs itself through the proliferation and growth of the dermis (fibroblasts and other stromal cells) and/or epidermis (keratinocytes and melanocytes) cells that remain. In extensive and deep skin and mucosal lesions, destruction of the dermal and epidermal elements may occur. This makes the regeneration process slow and subject to complications. In such cases, autologous skin transplantation may be used, but its use is limited by the extent of the donor site and by the patient's clinical condition. Allotransplants from cadavers or volunteers are rejected after one or two weeks and provide only temporary coverage. Human skin or devitalized animal grafts, which may be either lyophilized or cooled in glycerol, accommodate the connective tissue and stimulate the growth of blood vessels, but usually become degraded at an early stage.¹

Studies have been conducted with the aim of solving the problem of the need for large amounts of skin for transplantation in cases of burns and chronic skin ulcers, with scarce donor sites. These began by utilizing cells cultured in vitro, and experiments on both autologous^4,5 and non-autologous⁶ cells were attempted. Models of human epidermis reconstructed in vitro were developed,^7,8 but the clinical utilization of some of these models achieved only relative success. This was largely due to graft retraction problems caused by the absence of an adequate dermal bed (connective tissue)⁹ or the thinness of the grafts.¹⁰ More recently, the use of cells cultured in vitro in association with techniques to ensure adherence to the skin (fixing)^11-13 has been studied. The use of dermal substitutes or equivalents containing collagen, in association with autologous cells cultured in vitro, has also been studied and has provided better results.^14-16

The obtaining of skin containing associated dermis and epidermis, reconstructed with cells obtained from a small skin fragment, which is multiplied in the laboratory and usable in grafting, is still a theme to be explored. The utilization of acellular or collagen matrixes, for simultaneous growth of dermal and epidermal cells, has shown promising results.^17-19

Collagen tissue used as matrix for cultured growth of fibroblasts (in vitro) provides a dermal equivalent with characteristics very similar to those found in human dermis, with good prospects of clinical application.^20,21

The present study demonstrates a reproducible technique that can be rapidly implemented for obtaining human skin containing an association of dermis and epidermis, reconstructed in vitro. It is based on the culturing of fibroblasts inside a bovine collagen type I matrix, and sequential growth of keratinocytes and melanocytes on this collagen matrix.

OBJECTIVE

To demonstrate a method for obtaining human skin reconstructed in vitro composed of associated dermis and epidermis, using fibroblasts cultivated in bovine collagen type I matrix and keratinocytes and melanocytes cultivated on this matrix.

SETTING

Skin Cell Culture Laboratory of Faculdade de Ciências Médicas da Universidade Estadual de Campinas, Campinas, São Paulo, Brazil.

METHODS

SAMPLE COLLECTION

Skin samples were collected from patients undergoing surgical procedures on the breast and abdomen at the Teaching Hospital of Universidade Estadual de Campinas, São Paulo, Brazil, by staff from the Discipline of Plastic Surgery. This procedure was approved by and was in conformity with the norms of the Ethics Committee of Faculdade de Ciências Médicas, Universidade Estadual de Campinas, and with the Declaration of Helsinki of 1975, as amended in 1983.

PREPARATION OF CULTURE SAMPLES

Skin samples measuring 2.0 x 1.0 cm were collected and stored in sterile tempered glass jars, with preservation using 0.9% physiological serum at 4° C. All samples were processed within 12 hours of their collection.

The samples were separated from the adipose tissue and placed in jars with Hanks' Balanced Salt Solution (HBSS) (Gibco BRL, Grand Island, New York, United States, catalog no. 14025-092) plus antibiotic and antimycotic agents (sodium penicillin G, streptomycin and amphotericin B; Gibco catalog no. 15240-062). The whole skin samples were cut into smaller 1 to 2 mm fragments.

The liquid was removed from the jars, leaving behind the skin fragments, and 0.25% trypsin solution was added (Trypsin EDTA; Gibco catalog no. 25200-056). The jars were kept in an incubator at 37° C, with 5% CO₂ tension, for 4 hours, which resulted in separation of the dermis from the epidermis.

The trypsin was then neutralized with fetal bovine serum (Gibco catalog no. 10437-028). The supernatant liquid was recovered from the jars and filtered using a 40 µm nylon filter (Falcon), and then centrifuged at 1200 rpm for 10 minutes.

The precipitate (cells) was washed with Hanks' Balanced Salt Solution plus antibiotic and antimycotic agents, and again centrifuged. Following this, one aliquot was removed for manual cell counting in a Neubauer chamber, using the Trypan Blue exclusion method.

CELL CULTURING

After counting, the cells were distributed into culturing flasks (Corning), at a concentration of 1 x 10⁵ cells per cm². They were then incubated at 37° C, with 5% CO₂ tension, in specific culturing media for each cell type (keratinocytes, melanocytes and fibroblasts).

Culturing medium for keratinocytes: Keratinocyte culturing medium was used (Gibco catalog no. 10785-012), supplemented with L-glutamine 2 mM/ml, penicillin 100 UI/ml, streptomycin 0.1 mg/ml (Gibco catalog no. 10378-016) and fetal bovine serum 10%.

Culturing medium for melanocytes: Melanocyte culturing medium MCDB 153 was used (Sigma Chemical Co., St. Louis, Missouri, United States, M7403), supplemented with L-glutamine 2 mM/ml, penicillin 100 UI/ml, streptomycin 0.1 mg/ml, fetal bovine serum 10%, bovine pituitary extract 50 µg/ml (Gibco catalog no. 13028-014), hydrocortisone 0.6 µg/ml (Sigma H0888) and bovine insulin 3 µg/ml (Gibco catalog no. 13007-018).

Culturing medium for fibroblasts: Fibroblast culturing medium M199 was used (Gibco catalog no. 31100-035), supplemented with L-glutamine 2 mM/ml, penicillin 100 UI/ml, streptomycin 0.1 mg/ml and fetal bovine serum 10%.

For all the culturing media, the pH was maintained at around 7.8. The flasks were placed in an incubator at 37° C, with 5% CO₂ tension. The culturing media were changed three times a week. The passage of cultured cells was performed when the cells were confluent.

CELL PASSAGE

The culturing media in the flasks were removed. Trypsin 0.25% was added to each of the culturing flasks, which were placed in an incubator at 37° C, with 5% CO₂ tension, for 10 minutes.

The trypsin was neutralized with fetal bovine serum, and the liquid containing the cells was transferred from the flasks to 50 ml Falcon tubes, for centrifugation at 1200 rpm for 10 minutes. The medium was removed and the cells resuspended at the desired concentration, now in the specific culturing medium. The cells were placed in the culturing flasks in an incubator, at 37° C, with 5% CO₂ tension.

An average of 14 days was needed for obtaining sufficient number of cells (more than 2 x 10⁶), from each initial skin fragment measuring 2.0 x 1.0 cm. In about 21 days, a quantity of cells greater than 5 x 10⁶ was obtained.

These cells could be frozen in fetal bovine serum, with 10% dimethyl sulfoxide (DMSO; Sigma), in liquid nitrogen, and thus maintained for long periods. When they were thawed out, they presented viability of between 70 and 80%.

TECHNIQUE FOR OBTAINING HUMAN DERMIS RECONSTRUCTED IN VITRO

Permeable and porous acellular bovine collagen type I matrix (Gen-col., block collagen, code 961.25, Genius line, Baumer Biomaterials Division, Mogi Mirim, São Paulo, Brazil), measuring approximately 10 x 15 x 25 mm, was utilized. A syringe was utilized to inject into this matrix a quantity of 2.0 x 10⁶ fibroblasts, in an M199 culture medium, supplemented with L-glutamine 2 mM/ml, penicillin 100 UI/ml, streptomycin 0.1 mg/ml and fetal bovine serum 10%.

The collagen type I matrix containing fibroblasts was placed on a Petri dish of approximately 10 cm² and immersed in fibroblast culturing medium, supplemented with L-glutamine 2 mM/ml, penicillin 100 UI/ml, streptomycin 0.1 mg/ml and fetal bovine serum 10%. It was then placed in an incubator at 37° C, with 5% CO₂ tension.

The culturing medium was changed three times a week. The human dermis reconstructed in vitro was obtained in seven days.

TECHNIQUE FOR OBTAINING HUMAN SKIN RECONSTRUCTED IN VITRO CONTAINING ASSOCIATED DERMIS AND EPIDERMIS

On the human dermis reconstructed in vitro on the Petri dish, a quantity of 5 x 10⁶ mixed epidermal cells were seeded at a melanocyte to keratinocyte ratio of 1:4 (i.e. approximately 1 x 10⁶ melanocytes and 4 x 10⁶ keratinocytes). The system was immersed in skin culturing medium composed of three parts of Iscove's Modified Dulbecco's Medium (IMDM) (Gibco catalog no. 12200-036) plus one part of keratinocyte culturing medium, with 10% fetal bovine serum and Ca²⁺ 1.5 mM supplementation.

The culturing medium was changed three times a week. Human skin reconstructed in vitro containing associated dermis and epidermis was obtained in seven days (starting from the human dermis previously reconstructed in vitro).

CONTROL EXPERIMENT

A quantity of 2.0 x 10⁶ fibroblasts in an M199 culture medium were placed on a Petri dish of approximately 10 cm², and supplemented with L-glutamine 2 mM/ml, penicillin 100 UI/ml, streptomycin 0.1 mg/ml and fetal bovine serum 10%. The culturing medium was changed three times a week.

Seven days later, a quantity of 5 x 10⁶ mixed epidermal cells were seeded onto the Petri dish (melanocyte to keratinocyte ratio of 1:4). Skin culturing medium was added, composed of three parts IMDM plus one part keratinocyte culturing medium, with 10% fetal bovine serum and Ca²⁺ 1.5 mM supplementation. The culturing medium was changed three times a week.

After a further seven days, the skin obtained was removed from the culturing medium.

MORPHOLOGICAL STUDIES ON THE HUMAN SKIN RECONSTRUCTED IN VITRO CONTAINING ASSOCIATED DERMIS AND EPIDERMIS AND ON THE CONTROL EXPERIMENT

Human skin samples containing associated dermis and epidermis reconstructed in vitro using bovine collagen type I matrix, and the skin specimens obtained in control experiments, were fixed in formaldehyde 10% and embedded in paraffin. Histological sections of 4 mm in thickness were prepared and stained with hematoxylin-eosin (HE), Masson's trichrome and PAS (periodic acid-Schiff).

RESULTS

The experiment was successfully performed in triplicate, to validate the technique.

Macroscopically, both in the experiment to obtain human skin reconstructed in vitro, containing associated dermis and epidermis with utilization of bovine collagen type I, and in the control experiment, it was possible to observe the formation of a thin translucent pellicle. This was comparable, to the naked eye, to a very thin partial skin graft.

In the histological sections from the human skin reconstructed in vitro containing associated dermis and epidermis using collagen type I, it was possible to observe the following:

• Hematoxylin-eosin (HE): Clear distinction between dermis and epidermis. The epidermis was formed with three to four keratinocyte layers. These cells were cuboid at the base and flatter in the higher strata, with absence of the

  stratum granulosum and

  stratum corneum, and a wavy outer surface that had a cuticular appearance (

  Figure 1).

• Masson's trichrome: Clear dermal-epidermal border. Fibrillar extracellular matrix and fibroblasts in the dermis were organized in parallel to the epidermis (

  Figure 2).

• Periodic Acid-Schiff: Presence of fuchsinophil material (glycogen) in the cytoplasm of keratinocytes (

  Figure 3).

In the histological sections from the skin obtained in the control experiment, the following was observed:

• Hematoxylin-eosin (HE): Presence of mixed dermal and epidermal cells, with predominance of fibroblasts. Absence of organoid architecture (

  Figure 4).

• Masson's trichrome: The dermis was not distinguishable from the epidermis. The extracellular matrix was not observed (

  Figure 5).

• Periodic Acid- Schiff: No fuchsinophil material (glycogen) was observed in the cytoplasm of keratinocytes (

  Figure 6).

DISCUSSION

With the utilization of a bovine collagen type I matrix for fibroblast growth, in a selective culturing medium, a human dermis reconstructed in vitro that was similar to normal human dermis was obtained, with its cells (fibroblasts) organized in parallel within a three-dimensional structure (collagen).

On this human dermis reconstructed in vitro, a clearly differentiated human epidermis reconstructed in vitro was reproduced by keratinocyte and melanocyte culturing in a skin-adequate medium.

Therefore, through sequential culturing of dermal cells (fibroblasts) in a bovine collagen type I matrix, and of epidermal cells (keratinocytes and melanocytes) on this matrix, a human skin composed of associated dermis and epidermis reconstructed in vitro can be obtained. This reconstructed skin presents collagen in the dermis, and has fibroblasts, keratinocytes and melanocytes positioned in a manner analogous to the equivalent human skin, while maintaining the due thickness proportions in relation to human skin in vivo. The stratification of the epidermis in the human skin that was reconstructed in vitro containing associated dermis and epidermis has characteristics similar to those found in vivo. Human skin reconstructed in vitro containing associated dermis and epidermis was obtained in 14 days, starting from sufficient numbers of dermal cells (fibroblasts) and epidermal cells (melanocytes and keratinocytes).

In histological sections, the human skin reconstructed in vitro obtained in the control experiment presented dermal cells (fibroblasts) and epidermal cells (keratinocytes and melanocytes) without any architectural organization, and without any evidence of constituted dermis and epidermis. The failure to obtain human skin containing distinguishable dermis and epidermis through reconstruction in vitro in the control experiment confirms the importance of the utilization of a bovine collagen type I matrix to obtain a human skin reconstructed in vitro that is equivalent to human skin in vivo.

Collagen is available in abundance and can be easily purified from living organisms. It is biodegradable, bioabsorbable and nontoxic, and has low antigenicity and excellent biocompatibility, in comparison with other natural polymers like albumin and gelatin. Among the main applications of collagen in the field of medicine are its uses in ophthalmological prostheses and as sponges (biological dressings) for burns and skin ulcers. In tissue engineering, it is utilized as the basic matrix for the development of cell systems and in constructing artificial substitutes for vessels and valves.²²

One of the few disadvantages of pure collagen type I is that it has a relatively high cost. However, the high cost of treating skin lesions using this when grafting donor sites are scarce is perfectly justifiable because of the decreased treatment duration,^23,24 and also the better survival rates and the quality of the end result.²⁵ Clinical reactions to collagen are rare, but two cases of allergy to bovine collagen, mediated by immunoglobulin E (IgE), have been reported. In both of these cases, the patients developed conjunctival edema as a reaction to the topical application of highly purified bovine collagen to their eyes, during ophthalmological surgery.²⁶

The utilization of a bovine collagen type I membrane on an area of skin loss may lead to the formation of neodermis, through migration of the patient's own fibroblasts into the membrane, followed by cell multiplication and maturation. Spontaneous epithelization may take place over the neodermis, through epithelial growth occurring in the lateral region of the wound, or epithelization may be induced by placing autologous keratinocytes cultured in vitro on the neodermis.¹⁴ The possibility of clinical utilization of autologous human skin containing associated dermis and epidermis that is completely reconstructed in vitro is much more advantageous than the methods employed previously.

In the present study, skin samples measuring 2.0 x 1.0 cm were removed from the patients. In about two weeks, we had quantities of fibroblasts greater than 2 x 10⁶. In three weeks, we had quantities of fibroblasts greater than 5 x 10⁶ each, and melanocyte and keratinocyte quantities of around 5 x 10⁶ each. In four weeks, we had keratinocytes and melanocytes in a number higher than 20 x 10⁶. We needed 2 x 10⁶ fibroblasts and 5 x 10⁶ keratinocytes and melanocytes in a ratio of 4:1 (4 x 10⁶ keratinocytes and 1 x 10⁶ melanocytes), in order to obtain human skin fragments reconstructed in vitro measuring 2.0 x 2.0 cm after two weeks of culturing. Therefore, the method here presented offers the possibility of obtaining human skin, containing dermis and epidermis reconstructed in vitro, of twice the size of the original skin removed from the patient, by means of conventional cell culturing over a four-week period. The utilization of cell culturing acceleration methods²⁷ may supply sufficient numbers of cells for seeding inside the bovine collagen type I matrix in a shorter time, with a concomitant decrease in the time needed for obtaining human skin reconstructed in vitro.

The freezing of cells with maintenance of their viability for long periods offers a way of obtaining cells for culturing and consequent reconstitution of human skin containing autologous dermis and epidermis in vitro, in cases in which there is initial failure in the clinical treatment of skin ulcers and burns, without the need for new skin samples. Dimethyl sulfoxide is added to the fetal bovine serum at a concentration of 10% during the freezing process, to avoid cell crystallization.

While the epidermis is forming in the skin-culturing medium, on the bovine collagen type I matrix, it is essential to add Ca²⁺ at a concentration of 1.5 mM to the medium, so that the formation of a pellicle occurs at the location where the stratum corneum would be (Figure 1). This was demonstrated in previous studies that aimed at obtaining human epidermis reconstructed in vitro.^8,28 The pellicle formed during the process for obtaining human skin reconstructed in vitro composed of associated dermis and epidermis, where the stratum corneum would be located, is extremely thin. However, it may thicken if it is exposed to air (maintained at the air-liquid interface), thus forming a real stratum corneum.

This model for human skin reconstructed in vitro, containing associated dermis and epidermis, offers an excellent investigative system, particularly in relation to efficiency and toxicology tests on new chemical products and drugs in vitro. It has the advantage of presenting dermal components, in comparison with systems presented in studies that made use of the epidermis alone.^28,29

The present model is not expected to enable research on the immunological effects of reactions mediated by Langerhans cells or by ultraviolet-induced macrophages, as demonstrated in studies that made use of epidermis reconstructed in vitro separately.³⁰ However, this could be perfectly achieved by cultivating Langerhans cells separately,³¹ and introducing these cells together with keratinocytes and melanocytes seeded on the human dermis reconstructed in vitro, thus obtaining human skin reconstructed in vitro with immune function.

This model may also allow research on the physiopathology and possible therapeutic options for pigmentation disorders such as vitiligo, melasma and melanocytic nevus, for which the origin is still indeterminate. Several other models for human skin reconstructed in vitro, with a variety of laboratory, experimental and clinical applications, are expected to emerge and undergo investigation over the coming years.

We consider that the present model for human skin reconstructed in vitro, containing associated dermis and epidermis, is compatible with and similar to human skin in vivo. It presents advantages over previous models for artificial skin substitutes^21,32-34 and epidermis reconstructed in vitro.^10,11,13,35

CONCLUSIONS

It is possible to obtain sufficient numbers of cells from human fibroblast culturing that can be injected into a bovine collagen type I matrix, thereby enabling the formation of a human dermis reconstructed in vitro. Following this, through human keratinocyte and melanocyte culturing on this human dermis reconstructed in vitro, it is possible to obtain a completely differentiated human skin reconstructed in vitro, composed of associated dermis and epidermis.

We believe that the present model for human skin reconstructed in vitro has excellent applicability in relation to laboratory studies and good prospects for clinical use. Therefore, our next step would be to characterize this model for human skin reconstructed in vitro composed of associated dermis and epidermis, by means of immunohistochemical and molecular studies, with the aim of using it for treating burns and chronic skin ulcers.

Sources of funding: None

Conflict of interest: None

Date of first submission: November 18, 2004

Last received: May 23, 2005

Accepted: March 7, 2006

AUTHOR INFORMATION

Luís Ricardo Martinhão Souto, MD. Plastic surgeon and MSc student of Medical Sciences, Faculdade de Ciências Médicas, Universidade Estadual de Campinas (Unicamp), Campinas, São Paulo, Brazil.

Jussara Rehder. Chief biologist of the Molecular Biology and Skin Cell Culture Laboratory, Universidade Estadual de Campinas, Campinas (Unicamp), São Paulo, Brazil.

José Vassallo, MD, PhD. Associate professor of the Department of Pathological Anatomy, Faculdade de Ciências Médicas, Universidade Estadual de Campinas (Unicamp), Campinas, São Paulo, Brazil.

Maria Letícia Cintra, MD, PhD. Associate professor of the Department of Pathological Anatomy, Faculdade de Ciências Médicas, Universidade Estadual de Campinas (Unicamp), Campinas, São Paulo, Brazil.

Maria Helena Stangler Kraemer, MD, PhD. Associate professor of the Department of Clinical Pathology, Faculdade de Ciências Médicas, Universidade Estadual de Campinas (Unicamp), Campinas, São Paulo, Brazil.

Maria Beatriz Puzzi, MD, PhD. Associate professor of the Discipline of Dermatology, Department of Internal Medicine, and Head of the Skin Cell Culture Laboratory, Faculdade de Ciências Médicas, Universidade Estadual de Campinas (Unicamp), Campinas, São Paulo, Brazil.

• 1. Boranic M, Jakic-Razumovic J, Stanovic S, Kljenak A, Fattorini I. Kultura koznih stanica: primjena u plasticnoj kirurgiji i laboratorijskom istrazivanju. [Skin cell culture: utilization in plastic surgery and laboratory studies]. Lijec Vjesn. 1999;121(4-5):137-43.
• 2. Huang Y, Ren L, Qin Y. [Observation of cicatricial fibroblasts in culture and its biological properties]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 1998;12(6):332-5.
• 3. Watt FM. The epidermal keratinocyte. Bioessays. 1988;8(5):163-7.
• 4. Boss WK, Usal H, Fodor PB, Chernoff G. Autologous cultured fibroblasts: a protein repair system. Ann Plast Surg. 2000;44(5):536-42.
• 5. Terskikh VV, Vasiliev AV. Cultivation and transplantation of epidermal keratinocytes. Int Rev Cytol. 1999;188:41-72.
• 6. Bolívar-Flores YJ, Kuri-Harcuch W. Frozen allogeneic human epidermal cultured sheets for the cure of complicated leg ulcers. Dermatol Surg. 1999;25(8):610-7.
• 7. Régnier M, Patwardhan A, Scheynius A, Schimdt R. Reconstructed human epidermis composed of keratinocytes, melanocytes and Langerhans cells. Med Biol Eng Comput. 1998;36(6):821-4.
• 8. Pruniéras M, Régnier M, Woodley D. Methods for cultivation of keratinocytes with an air-liquid interface. J Invest Dermatol. 1983;81(1 Suppl):28s-33s.
• 9. El-Sheemy MA, Muir IF, Wheatley DN, Eremin O. Inhibition of the contraction of collagen gels by extracts from human dermis. Cell Biol Int. 2001;25(7):635-42.
• 10. Carsin H, Ainaud P, Le Bever H, et al. Cultured epithelial autografts in extensive burn coverage of severely traumatized patients: a five year single-center experience with 30 patients. Burns. 2000;26(4):379-87.
• 11. Horch RE, Bannasch H, Stark GB. Transplantation of cultured autologous keratinocytes in fibrin sealant biomatrix to resurface chronic wounds. Transplant Proc. 2001;33(1-2):642-4.
• 12. Horch RE, Bannasch H, Kopp J, Andree C, Stark GB. Single-cell suspensions of cultured human keratinocytes in fibrin-glue reconstitute the epidermis. Cell Transplant. 1998;7(3):309-17.
• 13. Ronfard V, Broly H, Mitchell V, et al. Use of human keratinocytes cultured on fibrin glue in the treatment of burns wounds. Burns. 1991;17(3):181-4.
• 14. Jansson K, Haegerstrand A, Kratz G. A biodegradable bovine collagen membrane as a dermal template for human in vivo wound healing. Scand J Plast Reconstr Surg Hand Surg. 2001;35(4):369-75.
• 15. Kremer M, Lang E, Berger AC. Evaluation of dermal-epidermal skin equivalents ('composite-skin') of human keratinocytes in a collagen-glycosaminoglycan matrix (Integra artificial skin). Br J Plast Surg. 2000;53(6):459-65.
• 16. Kim BM, Suzuki S, Nishimura Y, et al. Cellular artificial skin substitute produced by short period simultaneous culture of fibroblasts and keratinocytes. Br J Plast Surg. 1999;52(7):573-8.
• 17. Hoeller D, Huppertz B, Roos TC, et al. An improved and rapid method to construct skin equivalents from human hair follicles and fibroblasts. Exp Dermatol. 2001;10(4):264-71.
• 18. Auger FA, Rouabhia M, Goulet F, Berthod F, Moulin V, Germain L. Tissue-engineered human skin substitutes developed from collagen-populated hydrated gels: clinical and fundamental applications. Med Biol Eng Comput. 1998;36(6):801-12.
• 19. Archambault M, Yaar M, Gilchrest BA. Keratinocytes and fibroblasts in a human skin equivalent model enhance melanocyte survival and melanin synthesis after ultraviolet irradiation. J Invest Dermatol. 1995;104(5):859-67.
• 20. Vaissiere G, Chevallay B, Herbage D, Damour O. Comparative analysis of different collagen-based biomaterials as scaffolds for long-term culture of human fibroblasts. Med Biol Eng Comput. 2000;38(2):205-10.
• 21. Boyce ST. Skin substitutes from cultured cells and collagen-GAG polymers. Med Biol Eng Comput. 1998;36(6):791-800.
• 22. Lee CH, Singla A, Lee Y. Biomedical applications of collagen. Int J Pharm. 2001;221(1-2):1-22.
• 23. Horch RE, Debus M, Wagner G, Stark GB. Cultured human keratinocytes on type I collagen membranes to reconstitute the epidermis. Tissue Eng. 2000;6(1):53-67.
• 24. Miller PL, Matthey FC. A cost-benefit analysis of initial burn cultures in the management of acute burns. J Burn Care Rehabilit. 2000;21(4):300-3.
• 25. Chalumeau M, Saulnier JP, Ainaud P, et al. Initial general management and surgery of six extensively burned children treated with cultured epidermal autografts. J Pediatr Surg. 1999;34(4):602-5.
• 26. Mullins RJ, Richards C, Walker T. Allergic reactions to oral, surgical and topical bovine collagen. Anaphylactic risk for surgeons. Austr N Z J Ophthalmol. 1996:24(3):257-60.
• 27. Prenosil JE, Kino-oka M. Computer controlled bioreactor for large-scale production of cultured skin grafts. Ann N Y Acad Sci. 1999;875:386-97.
• 28. Régnier M, Caron D, Reichert U, Schaefer H. Reconstructed human epidermis: a model to study in vitro the barrier function of the skin. Skin Pharmacol. 1992;5(1):49-56.
• 29. Régnier M, Asselineau D, Lenoir MC. Human epidermis reconstructed on dermal substrates in vitro: an alternative to animals in skin pharmacology. Skin Pharmacol. 1990;3(2):70-85.
• 30. Bessou S, Surlève-Bazeille JE, Sorbier E, Taieb A. Ex vivo reconstruction of the epidermis with melanocytes and the influence of UVB. Pigment Cell Res. 1995;8(5):241-9.
• 31. Fransson J, Heffler LC, Tengvall Linder M, Scheynius A. Culture of human epidermal Langerhans cells in a skin equivalent. Br J Dermatol. 1998;139(4):598-604.
• 32. Nanchahal J, Dover R, Otto WR. Allogeneic skin substitutes applied to burns patients. Burns. 2002;28(3):254-7.
• 33. van Zuijlen PP, Vloemans JF, van Trier AJ, et al. Dermal substitution in acute burns and reconstructive surgery: a subjective and objective long-term follow-up. Plast Reconstr Surg. 2001;108(7):1938-46.
• 34. Hunt JA, Moisidis E, Haertsch P. Initial experience of Integra in the treatment of post-burn anterior cervical neck contracture. Br J Plast Surg. 2000;53(8):652-8.
• 35. Rehder J, Souto LR, Issa CM, Puzzi MB. Model of human epidermis reconstructed in vitro with keratinocytes and melanocytes on dead de-epidermized human dermis. Sao Paulo Med J. 2004;122(1):22-5.

Publication Dates

• Publication in this collection
  24 July 2006
• Date of issue
  2006

History

• Accepted
  07 Mar 2006
• Reviewed
  23 May 2005
• Received
  18 Nov 2004